The study focused on solid dosage forms, specifically tablets and capsules, which are the most common delivery methods for red yeast rice supplements. The researchers conducted a comprehensive evaluation based on the requirements of the European Pharmacopoeia, the twelfth edition, to assess mass uniformity, mechanical strength, resistance to crushing, friability, and disintegration. By analyzing these parameters, the team aimed to understand how formulation composition and dosage form influence the technological quality of the products. The findings indicate that while some products complied with all applicable requirements, others showed significant deviations, particularly in mass uniformity and disintegration times.

One of the most striking findings was the variability in the mechanical strength of the tablets. The mechanical strength ranged from 58.6 to 280 Newtons, with one sample exhibiting both the highest mechanical strength and the lowest friability. This sample also had the longest disintegration time, taking 40 minutes to fully break down, which exceeded the pharmacopeial limit of 15 minutes for uncoated tablets. In contrast, other uncoated tablets disintegrated in 20 to 30 minutes, but none met the 15-minute requirement. This discrepancy suggests that higher mechanical strength, often achieved through the use of binders like microcrystalline cellulose and polyvinylpyrrolidone, can inadvertently slow down the disintegration process, potentially affecting the bioavailability of the active ingredients.

The disintegration times for capsules were generally shorter than those for tablets, with hard gelatin capsules disintegrating in as little as five minutes. This rapid disintegration is attributed to the hydration and dissolution properties of the gelatin shell, which allows for quick release of the contents. However, two hard gelatin capsule samples failed the mass uniformity test, indicating inconsistencies in the amount of active ingredient per capsule. Such variability can lead to unpredictable therapeutic effects, as patients may receive doses that are significantly higher or lower than intended. The study underscores the importance of rigorous quality control in the manufacturing of capsule formulations, particularly those containing complex powder blends with poor flow properties.

The role of excipients in determining the quality of red yeast rice supplements was also explored. Excipients such as microcrystalline cellulose, polyvinylpyrrolidone, and hypromellose were found to contribute to mechanical resistance, while disintegrants like starch and croscarmellose promoted faster disintegration. The presence of lipophilic components and plant extracts further complicated the formulation, as these ingredients can affect the compressibility and homogeneity of the powder blend. The study suggests that manufacturers need to carefully balance the use of these excipients to achieve a product that is both mechanically stable and capable of rapid disintegration. This balance is crucial for ensuring that the active compounds are released efficiently in the gastrointestinal tract.

Regulatory frameworks for food supplements in the European Union are less stringent than those for medicinal products, which may contribute to the observed variability in quality. Food supplements are legally defined as foodstuffs and are subject to fewer quality requirements, allowing for greater flexibility in formulation and manufacturing. However, this flexibility can also lead to inconsistencies in product performance, as manufacturers may not adhere to the same rigorous testing protocols required for pharmaceuticals. The study highlights the need for improved standardization and systematic quality assessment to ensure the safety and efficacy of red yeast rice supplements. Without such measures, consumers may be at risk of receiving products that do not perform as expected.

The findings of this study align with previous research that has reported considerable variability in the quality of commercially available red yeast rice supplements. A recent comprehensive evaluation also found that a significant proportion of tablet formulations failed to meet pharmacopeial requirements for disintegration, while capsule formulations generally complied with the specifications. These consistent findings across different studies emphasize the need for enhanced regulatory oversight and stricter quality control measures. The variability in pharmaceutical-technological characteristics not only affects the performance of the supplements but also poses potential safety risks, particularly for individuals with pre-existing health conditions or those taking other medications.

As the global use of food supplements continues to rise, the importance of ensuring their quality and safety cannot be overstated. Red yeast rice supplements, with their potential to lower cholesterol levels, are particularly relevant for individuals seeking natural alternatives to statin therapy. However, the variability in product quality highlighted by this study serves as a cautionary note for consumers and healthcare providers. It is essential for manufacturers to adopt best practices in formulation and manufacturing to ensure that their products meet the highest quality standards. Additionally, regulatory bodies should consider implementing stricter guidelines for the testing and approval of food supplements to protect public health.

In conclusion, the pharmaceutical-technological evaluation of red yeast rice food supplements reveals significant variability in quality characteristics, particularly in mass uniformity and disintegration. While some products comply with pharmacopeial requirements, others show deviations that may affect their performance and safety. The study underscores the need for improved formulation optimization, greater standardization, and stricter control to ensure the consistent quality of these supplements. As consumers continue to turn to natural remedies for health management, it is crucial that these products are held to the same high standards as conventional medicines to ensure their efficacy and safety.

Subject of Research: Pharmaceutical-technological quality evaluation of red yeast rice food supplements

Article Title: Pharmaceutical technological evaluation of red yeast rice food supplements: Quality characteristics of tablets and capsules

Article References: Slavcheva, K., Gvozdeva, Y., Staynova, R., Georgieva, P., & Grekova, D. (2026). Pharmaceutical technological evaluation of red yeast rice food supplements: Quality characteristics of tablets and capsules. Pharmacia, 73, Article e208174. https://doi.org/10.3897/pharmacia.73.e208174

Image Credits: AI Generated

DOI: 10.3897/pharmacia.73.e208174

Keywords: red yeast rice, food supplements, pharmaceutical quality, disintegration, mass uniformity, mechanical strength, excipients, European Pharmacopoeia, cholesterol management, regulatory standards, Pharmaceutical, technological